Although HCV screening is feasible in people living with HIV, the gap between universal access and universal successful treatment is still not defined.We studied the rate of access and response to Direct Acting Antivirals (DAA) in a cohort of HIV/HCV seen for care in Italy.
Predictors of access and response to DAA in a cohort of human immunodeficincy virus/hepatitis C virus co-infected patients in Italy.
G Nunnari;G. F. Pellicanò.
2017-01-01
Abstract
Although HCV screening is feasible in people living with HIV, the gap between universal access and universal successful treatment is still not defined.We studied the rate of access and response to Direct Acting Antivirals (DAA) in a cohort of HIV/HCV seen for care in Italy.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
